Jeffrey Lee
San Diego, CANPI 1245488592
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $770 of the $1,040 with a category attached, or 74.1%. Boston Scientific accounts for 97.9% of it on its own, with 1 other manufacturer making up the rest. 2023 is the largest year on record at $654, 9.6 times the $68 reported in 2021.
Across 9 payments — averaging $115.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Bausch & Lomb Americas Inc.$21
Across 3 payments — averaging $200,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$602K
What the payments were for
- Travel & lodging$77074%
- Food & beverage$26926%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $1,018 |
| Bausch & Lomb Americas Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 36 | $395 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.